口腔乾燥症（ドライマウス疾患）治療薬の世界市場規模調査＆予測：タイプ別、製品別、流通チャネル別、地域別分析、2022-2029年

ドライマウスは、口の中の唾液の分泌に影響を与え、口の中を乾燥させる疾患です。

この疾患により、食事、会話、消化などの身体機能に悪影響が出る可能性があります。また、栄養失調になり、身体に悪影響を及ぼすこともあります。高用量の医薬品、抗うつ剤、催眠剤、抗炎症剤などが、これらの疾患の原因となっています。市場の成長は、がん治療における化学療法や放射線療法の採用の増加、シェーグレン症候群、HIV、糖尿病、アルツハイマー病などの疾患の有病率の増加、老人人口の増加といった重要な要因に支えられています。

米国疾病対策予防センター（CDC）は、毎年、約65万人のがん患者が外来腫瘍科クリニックで化学療法を受けていると推定しています。さらに、「糖尿病性口腔乾燥症における人工唾液（ASDIX）」と名付けられた研究があります。2020年7月に発表された「Aldiamed対プラセボの二重盲検試験」では、1型および2型糖尿病の方の口腔乾燥の治療において、Aldiamedスプレーがプラセボよりも優れていると結論づけられました。これらの研究は、口腔乾燥症の治療における人工唾液の補充が有効であることを示しています。しかし、効果的な治療法が入手できないことが、2022年から2029年の予測期間を通じて市場の成長を阻害しています。

世界の口腔乾燥症（ドライマウス疾患）治療薬市場の調査において考慮した主要地域は、アジア太平洋地域、北米、欧州、中南米、および世界のその他の地域です。北米は、口腔乾燥症の有病率の増加やHIV疾患の増加、ドライマウス啓発活動の増加により、全体的な市場シェアをリードしています。しかし、アジア太平洋地域は、糖尿病などの疾患の有病率の上昇と医療費の増加により、最も急速に成長する地域と予想されます。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を盛り込むよう設計されています。

また、市場の将来的な成長を定義する促進要因や課題などの重要な側面に関する詳細な情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

• 市場スナップショット
• 世界・セグメント別市場推定・予測、2019年～2029年
  • 口腔乾燥症（ドライマウス疾患）治療薬市場：地域別、2019年～2029年
  • 口腔乾燥症（ドライマウス疾患）治療薬市場：タイプ別、2019年～2029年
  • 口腔乾燥症（ドライマウス疾患）治療薬市場：製品別、2019年-2029年
  • 口腔乾燥症（ドライマウス疾患）治療薬市場：流通チャネル別、2019年～2029年
• 主な動向
• 調査手法
• 調査前提条件

第2章 口腔乾燥症（ドライマウス疾患）治療薬の世界市場定義と範囲

• 調査の目的
• 市場の定義と範囲
  • 調査対象範囲
  • 産業の進化
• 調査対象年
• 通貨換算レート

第3章 口腔乾燥症（ドライマウス疾患）治療薬の世界市場力学

• 口腔乾燥症（ドライマウス疾患）治療薬市場のインパクト分析（2019年～2029年）
  • 市場促進要因
    • がん治療における化学療法および放射線療法の採用の増加
    • シェーグレン症候群、HIV、糖尿病、アルツハイマー病などの疾病の有病率の上昇
    • 老年人口層の増加
  • 市場の課題
    • 効果的な治療法の入手不可能性
  • 市場機会
    • 研究開発活動の活発化
    • 新製品導入の増加

第4章 口腔乾燥症（ドライマウス疾患）治療薬の世界市場産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
• PEST分析
  • 政治的
  • 経済的
  • 社会的
  • 技術的
• 投資採用モデル
• アナリストの結論・提言
• トップ投資機会
• 主要成功戦略

第5章 リスク評価：COVID-19のインパクト

• COVID-19が業界に与える全体的な影響の評価
• COVID-19以前とCOVID-19以後の市場シナリオ

第6章 口腔乾燥症（ドライマウス疾患）治療薬の世界市場、タイプ別

• 市場スナップショット
• 口腔乾燥症（ドライマウス疾患）治療薬の世界市場：タイプ別、業績-潜在的分析
• 口腔乾燥症（ドライマウス疾患）治療薬の世界市場タイプ別推定・予測2019-2029
• 口腔乾燥症（ドライマウス疾患）治療薬市場、サブセグメント分析
  • 人工唾液/唾液代替物
  • 唾液分泌促進剤

第7章 口腔乾燥症（ドライマウス疾患）治療薬の世界市場：製品別

• 市場スナップショット
• 口腔乾燥症（ドライマウス疾患）治療薬の世界市場：製品別、性能-ポテンシャル分析
• 口腔乾燥症（ドライマウス疾患）治療薬の世界市場、製品別推定・予測2019-2029
• 口腔乾燥症（ドライマウス疾患）治療薬市場、サブセグメント分析
  • 薬物
  • 唾液腺
  • その他の製品タイプ

第8章 口腔乾燥症（ドライマウス疾患）治療薬の世界市場：流通チャネル別

• 市場スナップショット
• 口腔乾燥症（ドライマウス疾患）治療薬の世界市場：流通チャネル別、業績-潜在能力分析
• 口腔乾燥症（ドライマウス疾患）治療薬の世界市場、流通チャネル別推定・予測2019～2029年
• 口腔乾燥症（ドライマウス疾患）治療薬市場、サブセグメント分析
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第9章 口腔乾燥症（ドライマウス疾患）治療薬の世界市場：地域別分析

• 口腔乾燥症（ドライマウス疾患）治療薬市場、地域別市場スナップショット
• 北米
  • 米国
    • タイプ別の推定・予測、2019-2029年
    • 製品別の推定・予測、2019-2029年
    • 流通チャネル別の推定・予測、2019年～2029年
  • カナダ
• 欧州口腔乾燥症（ドライマウス疾患）治療薬市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他の欧州地域
• アジア太平洋地域の口腔乾燥症（ドライマウス疾患）治療薬市場スナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカの口腔乾燥症（ドライマウス疾患）治療薬市場スナップショット
  • ブラジル
  • メキシコ
• 世界のその他の地域

第10章 競合情報

• トップ市場戦略
• 企業プロファイル
  • Lupin Limited
    • 主要情報
    • 概要
    • 財務情報（データの入手状況により異なります）
    • 製品概要
    • 最近の動向
  • Quest Products, Inc.
  • Parnell Pharmaceuticals, Inc.
  • Fresenius SE & Co. KGaA
  • Hikma Pharmaceuticals PLC
  • Sun Pharmaceutical Industries Ltd
  • GlaxoSmithKline PLC
  • ADVANZ PHARMA Corp. Limited
  • Pharmascience Inc
  • Synedgen, Inc.

第11章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • バリデーション
  • 出版
• 調査属性
• 調査の前提条件

LIST OF TABLES

• TABLE 1. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, report scope
• TABLE 2. Global Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by region 2019-2029 (USD Billion)
• TABLE 3. Global Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by Type 2019-2029 (USD Billion)
• TABLE 4. Global Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by Product 2019-2029 (USD Billion)
• TABLE 5. Global Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
• TABLE 6. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 17. U.S. Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. U.S. Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 19. Canada Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 20. Canada Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. Canada Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 22. UK Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 23. UK Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. UK Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 25. Germany Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 26. Germany Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. Germany Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 28. France Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 29. France Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. France Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 31. Italy Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 32. Italy Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Italy Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 34. Spain Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 35. Spain Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. Spain Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 37. RoE Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 38. RoE Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. RoE Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 40. China Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 41. China Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. China Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 43. India Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 44. India Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. India Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 46. Japan Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 47. Japan Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. Japan Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 49. South Korea Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 50. South Korea Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. South Korea Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 52. Australia Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 53. Australia Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. Australia Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. RoAPAC Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 58. Brazil Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 59. Brazil Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Brazil Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 61. Mexico Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 62. Mexico Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. Mexico Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 64. RoLA Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 65. RoLA Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. RoLA Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 67. Row Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 68. Row Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. Row Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 70. List of secondary sources, used in the study of global Xerostomia (Dry Mouth Disease) Therapeutics Market
• TABLE 71. List of primary sources, used in the study of global Xerostomia (Dry Mouth Disease) Therapeutics Market
• TABLE 72. Years considered for the study
• TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, research methodology
• FIG 2. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, key trends 2021
• FIG 5. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, growth prospects 2022-2029
• FIG 6. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, porters 5 force model
• FIG 7. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, pest analysis
• FIG 8. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, value chain analysis
• FIG 9. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, regional snapshot 2019 & 2029
• FIG 15. North America Xerostomia (Dry Mouth Disease) Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Xerostomia (Dry Mouth Disease) Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Xerostomia (Dry Mouth Disease) Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 19. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Xerostomia (Dry Mouth Disease) Therapeutics Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 4.25% over the forecast period 2022-2029. A medical disorder known as dry mouth causes the mouth to become dry by affecting saliva production in the mouth. Body functions including eating, speaking, and digestion may be negatively impacted by this disorder. Malnutrition may result from this and have a harmful effect on the body. High dosage pharmaceuticals, antidepressants, hypnotics, anti-inflammatory meds, and other substances are the cause of these diseases. The market growth is supported by significant factors such as increasing adoption of chemotherapy and radiotherapy in cancer treatment, growing prevalence of diseases such as Sjogren's Syndrome, HIV, diabetes, Alzheimer's disease, and others and a growing geriatric population base.

The Centers for Disease Control and Prevention (CDC) estimate that each year, around 650,000 cancer patients get chemotherapy in an ambulatory oncology clinic. Additionally, a study named "Artificial Saliva in Diabetic Xerostomia (ASDIX): Double Blind Trial of Aldiamed Versus Placebo" that was released in July 2020 concluded that Aldiamed spray was superior to a placebo in treating xerostomia in people with type 1 and type 2 diabetes. These studies show that the use of artificial saliva replacements in the treatment of xerostomia is effective. However, the nonavailability of effective treatment stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Xerostomia (Dry Mouth Disease) Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is leading the overall market share owing to the increasing prevalence of xerostomia and increase in HIV disease coupled with the increase in dry mouth awareness initiatives. However, Asia Pacific is expected to be the fastest growing region due to the rising prevalence of diseases such as diabetes and growing healthcare expenditure.

Major market players included in this report are:

Lupin Limited

Quest Products, Inc.

Parnell Pharmaceuticals, Inc.

Fresenius SE & Co. KGaA

Hikma Pharmaceuticals PLC

Sun Pharmaceutical Industries Ltd

GlaxoSmithKline PLC

ADVANZ PHARMA Corp. Limited

Pharmascience Inc

Synedgen, Inc.

Recent Developments in the Market:

In April 2021, Parnell Pharmaceuticals, Inc. launched the Mouth Kote-MD mouthwash based on MycoDelens, a proprietary substance created and licenced by New Mexico Tech University.

Virginia Head & Neck Therapeutics, Inc. introduced Voutia in February 2021, a medication that continuously relieves xerostomia (commonly known as chronic dry mouth). For the millions of people who experience this painful and frequently disabling illness, the unique, FDA-approved device provides a whole new strategy.

Global Xerostomia (Dry Mouth Disease) Therapeutics Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Type, Product, Distribution Channel, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.

The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Artificial Saliva/Saliva Substitutes

Salivary Stimulants

By Type:

Drugs

Salivary Pens

Other Product Types

By Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Xerostomia (Dry Mouth Disease) Therapeutics Market, by region, 2019-2029 (USD Billion)
  • 1.2.2. Xerostomia (Dry Mouth Disease) Therapeutics Market, by Type, 2019-2029 (USD Billion)
  • 1.2.3. Xerostomia (Dry Mouth Disease) Therapeutics Market, by Product, 2019-2029 (USD Billion)
  • 1.2.4. Xerostomia (Dry Mouth Disease) Therapeutics Market, by Distribution Channel, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Dynamics

• 3.1. Xerostomia (Dry Mouth Disease) Therapeutics Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing adoption of chemotherapy and radiotherapy in cancer treatment
    • 3.1.1.2. Growing prevalence of diseases such as Sjogren's Syndrome, HIV, diabetes, Alzheimer's disease, and others.
    • 3.1.1.3. Growing geriatric population base
  • 3.1.2. Market Challenges
    • 3.1.2.1. Nonavailability of effective treatment
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Increasing research and development activities
    • 3.1.3.2. Rising introduction of novel products

Chapter 4. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, by Type

• 6.1. Market Snapshot
• 6.2. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by Type, Performance - Potential Analysis
• 6.3. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
• 6.4. Xerostomia (Dry Mouth Disease) Therapeutics Market, Sub Segment Analysis
  • 6.4.1. Artificial Saliva/Saliva Substitutes
  • 6.4.2. Salivary Stimulants

Chapter 7. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, by Product

• 7.1. Market Snapshot
• 7.2. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by Product, Performance - Potential Analysis
• 7.3. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
• 7.4. Xerostomia (Dry Mouth Disease) Therapeutics Market, Sub Segment Analysis
  • 7.4.1. Drugs
  • 7.4.2. Salivary Pens
  • 7.4.3. Other Product Types

Chapter 8. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, by Distribution Channel

• 8.1. Market Snapshot
• 8.2. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by Distribution Channel, Performance - Potential Analysis
• 8.3. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
• 8.4. Xerostomia (Dry Mouth Disease) Therapeutics Market, Sub Segment Analysis
  • 8.4.1. Hospital Pharmacy
  • 8.4.2. Retail Pharmacy
  • 8.4.3. Online Pharmacy

Chapter 9. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, Regional Analysis

• 9.1. Xerostomia (Dry Mouth Disease) Therapeutics Market, Regional Market Snapshot
• 9.2. North America Xerostomia (Dry Mouth Disease) Therapeutics Market
  • 9.2.1. U.S. Xerostomia (Dry Mouth Disease) Therapeutics Market
    • 9.2.1.1. Type breakdown estimates & forecasts, 2019-2029
    • 9.2.1.2. Product breakdown estimates & forecasts, 2019-2029
    • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
  • 9.2.2. Canada Xerostomia (Dry Mouth Disease) Therapeutics Market
• 9.3. Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Snapshot
  • 9.3.1. U.K. Xerostomia (Dry Mouth Disease) Therapeutics Market
  • 9.3.2. Germany Xerostomia (Dry Mouth Disease) Therapeutics Market
  • 9.3.3. France Xerostomia (Dry Mouth Disease) Therapeutics Market
  • 9.3.4. Spain Xerostomia (Dry Mouth Disease) Therapeutics Market
  • 9.3.5. Italy Xerostomia (Dry Mouth Disease) Therapeutics Market
  • 9.3.6. Rest of Europe Xerostomia (Dry Mouth Disease) Therapeutics Market
• 9.4. Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Snapshot
  • 9.4.1. China Xerostomia (Dry Mouth Disease) Therapeutics Market
  • 9.4.2. India Xerostomia (Dry Mouth Disease) Therapeutics Market
  • 9.4.3. Japan Xerostomia (Dry Mouth Disease) Therapeutics Market
  • 9.4.4. Australia Xerostomia (Dry Mouth Disease) Therapeutics Market
  • 9.4.5. South Korea Xerostomia (Dry Mouth Disease) Therapeutics Market
  • 9.4.6. Rest of Asia Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market
• 9.5. Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Snapshot
  • 9.5.1. Brazil Xerostomia (Dry Mouth Disease) Therapeutics Market
  • 9.5.2. Mexico Xerostomia (Dry Mouth Disease) Therapeutics Market
• 9.6. Rest of The World Xerostomia (Dry Mouth Disease) Therapeutics Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Lupin Limited
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Product Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. Quest Products, Inc.
  • 10.2.3. Parnell Pharmaceuticals, Inc.
  • 10.2.4. Fresenius SE & Co. KGaA
  • 10.2.5. Hikma Pharmaceuticals PLC
  • 10.2.6. Sun Pharmaceutical Industries Ltd
  • 10.2.7. GlaxoSmithKline PLC
  • 10.2.8. ADVANZ PHARMA Corp. Limited
  • 10.2.9. Pharmascience Inc
  • 10.2.10. Synedgen, Inc.

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption